theory clinical_2_2
imports Main

begin

typedecl entity
typedecl event

consts
  SyntheticLethality :: "entity ⇒ bool"
  Occurs :: "event ⇒ bool"
  CoOccurrence :: "entity ⇒ bool"
  GeneticEvents :: "entity ⇒ bool"
  Loss :: "entity ⇒ bool"
  BRCA2 :: "entity ⇒ bool"
  Results :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  CellDeath :: "entity ⇒ bool"
  Inability :: "event ⇒ bool"
  Repair :: "event ⇒ bool"
  DNA :: "entity ⇒ bool"
  Damage :: "entity ⇒ bool"
  Pathways :: "entity ⇒ bool"
  Multiple :: "entity ⇒ bool"
  PARPInhibitors :: "entity ⇒ bool"
  Cause :: "event ⇒ bool"
  ReplicationAssociated :: "entity ⇒ bool"
  DoubleStrandBreaks :: "entity ⇒ bool"
  Prevent :: "event ⇒ bool"
  SingleStrandBreakRepair :: "entity ⇒ bool"
  Force :: "event ⇒ bool"
  Cells :: "entity ⇒ bool"
  Rely :: "event ⇒ bool"
  On :: "event ⇒ entity ⇒ bool"
  DefectiveHomologousRecombinationRepair :: "entity ⇒ bool"
  ErrorProneNonHomologousEndJoining :: "entity ⇒ bool"
  BRCA2Loss :: "entity ⇒ bool"
  Context :: "entity ⇒ bool"
  Mechanism :: "entity ⇒ bool"
  Singular :: "entity ⇒ bool"
  Cumulative :: "entity ⇒ bool"
  PrimaryRepairPathways :: "entity ⇒ bool"
  Compromised :: "entity ⇒ bool"
  Patients :: "entity ⇒ bool"
  Inhibition :: "entity ⇒ bool"
  PARP1 :: "entity ⇒ bool"
  Benefit :: "event ⇒ bool"

(* Explanation 1: Synthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of BRCA2, results in cell death due to the inability to repair DNA damage through multiple pathways. *)
axiomatization where
  explanation_1: "∃x y z e1 e2 e3 e4. SyntheticLethality x ∧ Occurs e1 ∧ CoOccurrence y ∧ GeneticEvents y ∧ Loss z ∧ BRCA2 z ∧ Results e2 ∧ Agent e2 y ∧ Patient e2 e3 ∧ CellDeath e3 ∧ Inability e4 ∧ Repair e4 ∧ Agent e4 y ∧ Patient e4 u ∧ DNA u ∧ Damage u ∧ Pathways v ∧ Multiple v"

(* Explanation 2: PARP inhibitors cause replication-associated double strand breaks by preventing single strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA. *)
axiomatization where
  explanation_2: "∃x y z w e1 e2 e3 e4 e5. PARPInhibitors x ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ ReplicationAssociated y ∧ DoubleStrandBreaks y ∧ Prevent e2 ∧ Agent e2 x ∧ Patient e2 z ∧ SingleStrandBreakRepair z ∧ Force e3 ∧ Agent e3 x ∧ Patient e3 w ∧ Cells w ∧ Rely e4 ∧ Agent e4 w ∧ On e4 v ∧ DefectiveHomologousRecombinationRepair v ∧ ErrorProneNonHomologousEndJoining v ∧ Repair e5 ∧ Agent e5 w ∧ Patient e5 u ∧ DNA u"

(* Explanation 3: In the context of BRCA2 loss, synthetic lethality causes cells to rely on a singular mechanism to repair cumulative DNA damage, as the primary repair pathways are compromised. *)
axiomatization where
  explanation_3: "∃x y z w e1 e2 e3 e4. BRCA2Loss x ∧ Context x ∧ SyntheticLethality y ∧ Cause e1 ∧ Agent e1 y ∧ Patient e1 z ∧ Cells z ∧ Rely e2 ∧ Agent e2 z ∧ On e2 v ∧ Mechanism v ∧ Singular v ∧ Repair e3 ∧ Agent e3 z ∧ Patient e3 u ∧ Cumulative u ∧ DNA u ∧ Damage u ∧ PrimaryRepairPathways w ∧ Compromised w"

theorem hypothesis:
  assumes asm: "Patients x ∧ Loss y ∧ BRCA2 y ∧ Inhibition z ∧ PARP1 z"
  (* Hypothesis: Patients with loss of BRCA2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA *)
  shows "∃x y z e1 e2 e3 e4. Patients x ∧ Loss y ∧ BRCA2 y ∧ Inhibition z ∧ PARP1 z ∧ Benefit e1 ∧ Agent e1 x ∧ Patient e1 z ∧ SyntheticLethality e2 ∧ Cause e2 e3 ∧ Cells w ∧ Agent e3 w ∧ Rely e3 ∧ On e3 v ∧ Mechanism v ∧ Repair e4 ∧ Agent e4 w ∧ Patient e4 u ∧ Damage u ∧ DNA u ∧ Cumulative u"
  sledgehammer
  oops

end
